E-viri
PDF
Recenzirano
Odprti dostop
-
Hartzell, Joshua D.; Neff, Robert; Ake, Julie; Howard, Robin; Olson, Stephen; Paolino, Kristopher; Vishnepolsky, Mark; Weintrob, Amy; Wortmann, Glenn
Clinical infectious diseases, 06/2009, Letnik: 48, Številka: 12Journal Article
The incidence of acute renal failure, defined by the risk, injury, or failure criteria of the RIFLE criteria (risk, injury, failure, loss, and end-stage kidney disease), in 66 patients who received colistimethate sodium was 45%, and 21% of patients stopped therapy because of nephrotoxicity. The RIFLE criteria should be used in the future to allow for comparison of nephrotoxicity among studies.
